BioCentury | Feb 5, 2019
Distillery Therapeutics

Cancer

...Moderna Inc., Cambridge, Mass. email: joshua.frederick@modernatx.com Sandi Wong Moderna Inc. Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) (CTLA4) (CD152) Interleukin-23 (IL-23) Interleukin-36 gamma (IL-36gamma) OX40...
BioCentury | Jan 31, 2019
Preclinical News

Moderna's triplet mRNA therapy treats checkpoint inhibitor-resistant tumors in mice

...durvalumab (MEDI4736) mRNA-2752 tremelimumab (CP-675, CP-675,206, CP-675206, ticilimumab) AstraZeneca plc Moderna Inc. Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) (CTLA4) (CD152) Interleukin-23 (IL-23) Interleukin-36 gamma (IL-36gamma) OX40...
Items per page:
1 - 2 of 2